IQVIA Holdings Inc
IQV179.560USD
+2.870+1.62%
Close 09/26, 16:00（ET）Quotes delayed by 15 min
30.53BMarket Cap
24.68P/E TTM
More Details of Company
Company Info
Ticker SymbolIQV
Company nameIQVIA Holdings Inc
IPO dateMay 09, 2013
CEOMr. Ari Bousbib
Number of employees88000
Security typeOrdinary Share
Fiscal year-endMay 09
Address2400 Ellis Road
CityDURHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code27703
Phone19199982000
Websitehttps://ir.iqvia.com/
Ticker SymbolIQV
IPO dateMay 09, 2013
CEOMr. Ari Bousbib
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Americas
1.81B
47.19%
Europe & Africa Region
1.22B
31.97%
Asia Pacific Region
798.00M
20.84%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Sep 12
Updated: Fri, Sep 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.53%
Harris Associates L.P.
6.91%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Global Advisors (US)
4.49%
GIC Private Limited
3.85%
Other
67.71%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.53%
Harris Associates L.P.
6.91%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Global Advisors (US)
4.49%
GIC Private Limited
3.85%
Other
67.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.27%
Investment Advisor/Hedge Fund
33.89%
Hedge Fund
7.17%
Sovereign Wealth Fund
4.97%
Pension Fund
4.19%
Research Firm
2.30%
Bank and Trust
2.11%
Individual Investor
0.91%
Family Office
0.16%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
2023Q1
1870
169.28M
91.24%
-7.20M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
19.76M
11.42%
-293.38K
-1.46%
Mar 31, 2025
Harris Associates L.P.
11.17M
6.46%
-166.29K
-1.47%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.88M
5.71%
-196.58K
-1.95%
Mar 31, 2025
State Street Global Advisors (US)
7.72M
4.46%
-157.55K
-2.00%
Mar 31, 2025
GIC Private Limited
6.54M
3.78%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.24M
2.45%
+59.53K
+1.43%
Mar 31, 2025
CPP Investment Board
4.59M
2.66%
+312.81K
+7.31%
Mar 31, 2025
Farallon Capital Management, L.L.C.
3.41M
1.97%
+288.70K
+9.24%
Mar 31, 2025
AllianceBernstein L.P.
3.54M
2.04%
-57.68K
-1.60%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
6.16%
Langar Global HealthTech ETF
5.44%
VanEck Biotech ETF
5.19%
Global X HealthTech ETF
4.77%
iShares Biotechnology ETF
3.15%
Adaptive Core ETF
2.75%
Fidelity Digital Health ETF
2.47%
Oakmark US Large Cap ETF
2.42%
American Century Focused Large Cap Value ETF
2.26%
Running Oak Efficient Growth ETF
2.21%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion6.16%
Langar Global HealthTech ETF
Proportion5.44%
VanEck Biotech ETF
Proportion5.19%
Global X HealthTech ETF
Proportion4.77%
iShares Biotechnology ETF
Proportion3.15%
Adaptive Core ETF
Proportion2.75%
Fidelity Digital Health ETF
Proportion2.47%
Oakmark US Large Cap ETF
Proportion2.42%
American Century Focused Large Cap Value ETF
Proportion2.26%
Running Oak Efficient Growth ETF
Proportion2.21%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
